{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:08:43Z","timestamp":1786118923025,"version":"build-2736575974"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVES:<\/jats:title>\n                    <jats:p>To estimate the occurrence rate of venous thromboembolism (VTE) among critically ill children and young adults with diabetic ketoacidosis (DKA) and evaluate putative prothrombotic risk factors using a multicenter data registry.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>DESIGN:<\/jats:title>\n                    <jats:p>Multicenter, observational, retrospective study utilizing a cohort derived from the Virtual Pediatric Systems database from October 1, 2014, to December 31, 2023.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>SETTING:<\/jats:title>\n                    <jats:p>One hundred thirty-nine North American PICUs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>PATIENTS:<\/jats:title>\n                    <jats:p>Critically ill children and young adults older than 30 days to younger than 21 years old with principal admission diagnosis of DKA, excluding neonates, postcardiac surgical patients, and children with length of stay (LOS) less than 1 day.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>INTERVENTIONS:<\/jats:title>\n                    <jats:p>None.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>MEASUREMENTS AND MAIN RESULTS:<\/jats:title>\n                    <jats:p>\n                      Of 21,549 encounters, 62 (0.29%) developed VTE (mean annual rate, 0.29% \u00b1 0.06%) and 32 of 62 (55%) were hospital-acquired VTE. Patients with, as compared to without, VTE experienced greater rates of sepsis (43.6% vs. 0.7%), cerebral edema (17.7% vs. 3.1%), central venous catheterization (CVC: 66.1% vs. 3.8%), invasive mechanical ventilation (46.8% vs. 2.3%), and a greater LOS (median, 4.9 d [interquartile range (IQR), 2.6\u201312.2 d] vs. 1.4 d [IQR, 1.1\u20131.9 d]; all\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      &lt; 0.001). Regarding DKA-specific prothrombotic risk factors, those with (as compared to without) VTE had more severe acidosis (median admission pH, 6.96 [IQR, 6.82\u20137.13] vs. 7.07 [IQR, 6.96\u20137.18]), hyperglycemia (median, 590\u2009mg\/dL [IQR, 453\u2013834\u2009mg\/dL] vs. 406\u2009mg\/dL [IQR, 310\u2013548\u2009mg\/dL]), and reduced Glasgow Coma Scale scores (median, 12 [IQR, 6\u201314] vs. 15 [IQR, 14\u201315]; all\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      &lt; 0.001). In an adjusted model, the presence of a CVC (adjusted odds ratio, 23.27; 95% CI, 6.63\u201381.6;\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      &lt; 0.001) and concurrent sepsis\/infection (odds ratio, 6.69; 95% CI, 2.37\u201318.87;\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      &lt; 0.001) were associated with VTE.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS:<\/jats:title>\n                    <jats:p>In this multicenter observational study of critically ill children and young adults hospitalized with DKA, the estimated occurrence rate of VTE was 0.29% and, in an adjusted model, associated with CVC and concurrent infection\/sepsis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/pcc.0000000000003769","type":"journal-article","created":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T10:05:55Z","timestamp":1748513155000},"page":"e924-e934","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Diabetic Ketoacidosis and Venous Thromboembolism: A North American Virtual Pediatric Systems Registry Study, 2014\u20132023"],"prefix":"10.1097","volume":"26","author":[{"given":"Kristin M.","family":"DeMayo","sequence":"first","affiliation":[{"name":"Department of Pediatrics, University of South Florida Morsani College of Medicine, Tampa, FL."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth E.","family":"Havlicek","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Utah School of Medicine, Salt Lake City, UT."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie","family":"Palumbo","sequence":"additional","affiliation":[{"name":"Virtual Pediatric Systems, LLC, Division of Analytics, Los Angeles, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerardo","family":"Soto-Campos","sequence":"additional","affiliation":[{"name":"Virtual Pediatric Systems, LLC, Division of Analytics, Los Angeles, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marisol","family":"Betensky","sequence":"additional","affiliation":[{"name":"Institute for Clinical and Translational Research, Johns Hopkins All Children\u2019s Hospital, St. Petersburg, FL."},{"name":"Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD."},{"name":"Cancer and Blood Disorders Institute, Johns Hopkins All Children\u2019s Hospital, St. Petersburg, FL."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil A.","family":"Goldenberg","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of South Florida Morsani College of Medicine, Tampa, FL."},{"name":"Institute for Clinical and Translational Research, Johns Hopkins All Children\u2019s Hospital, St. Petersburg, FL."},{"name":"Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD."},{"name":"Cancer and Blood Disorders Institute, Johns Hopkins All Children\u2019s Hospital, St. Petersburg, FL."},{"name":"Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6290-4975","authenticated-orcid":false,"given":"Anthony A.","family":"Sochet","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of South Florida Morsani College of Medicine, Tampa, FL."},{"name":"Institute for Clinical and Translational Research, Johns Hopkins All Children\u2019s Hospital, St. Petersburg, FL."},{"name":"Department of Anesthesiology and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, MD."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,5,29]]},"reference":[{"key":"R1-20250703","doi-asserted-by":"crossref","first-page":"e2021054649","DOI":"10.1542\/peds.2021-054649","article-title":"The continued rise of venous thromboembolism across US children\u2019s hospitals.","volume":"149","author":"O\u2019Brien","year":"2022","journal-title":"Pediatrics"},{"key":"R2-20250703","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1182\/bloodadvances.2017013292","article-title":"Increasing rate of pulmonary embolism diagnosed in hospitalized children in the United States from 2001 to 2014.","volume":"2","author":"Carpenter","year":"2018","journal-title":"Blood Adv"},{"key":"R3-20250703","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/pbc.23388","article-title":"Pediatric venous thromboembolism in the United States: A tertiary care complication of chronic diseases.","volume":"59","author":"Setty","year":"2012","journal-title":"Pediatr Blood Cancer"},{"key":"R4-20250703","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.jpeds.2011.03.052","article-title":"Pediatric venous and arterial noncerebral thromboembolism in Denmark: A nationwide population-based study.","volume":"159","author":"Tuckuviene","year":"2011","journal-title":"J Pediatr"},{"key":"R5-20250703","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1055\/s-0041-1722847","article-title":"Venous thromboembolism among critically ill children: A narrative review.","volume":"47","author":"Sochet","year":"2021","journal-title":"Semin Thromb Hemost"},{"key":"R6-20250703","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1097\/PCC.0b013e318207124a","article-title":"Incidence and risk factors associated with venous thrombotic events in pediatric intensive care unit patients.","volume":"12","author":"Higgerson","year":"2011","journal-title":"Pediatr Crit Care Med"},{"key":"R7-20250703","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.thromres.2015.04.036","article-title":"Development of a new risk score for hospital-associated venous thromboembolism in critically-ill children not undergoing cardiothoracic surgery.","volume":"136","author":"Arlikar","year":"2015","journal-title":"Thromb Res"},{"key":"R8-20250703","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/PCC.0000000000002826","article-title":"A new risk assessment model for hospital-acquired venous thromboembolism in critically ill children: A report from the children\u2019s hospital-acquired thrombosis consortium.","volume":"23","author":"Jaffray","year":"2022","journal-title":"Pediatr Crit Care Med"},{"key":"R9-20250703","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jpeds.2018.05.006","article-title":"Epidemiology of lower extremity deep venous thrombosis in critically ill adolescents.","volume":"201","author":"Faustino","year":"2018","journal-title":"J Pediatr"},{"key":"R10-20250703","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/jth.14697","article-title":"Comparative validation study of risk assessment models for pediatric hospital-acquired venous thromboembolism.","volume":"18","author":"Mahajerin","year":"2020","journal-title":"J Thromb Haemost"},{"key":"R11-20250703","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0049-3848(03)00099-9","article-title":"An open-label randomized controlled trial of low molecular weight heparin for the prevention of central venous line-related thrombotic complications in children: The PROTEKT trial.","volume":"109","author":"Massicotte","year":"2003","journal-title":"Thromb Res"},{"key":"R12-20250703","doi-asserted-by":"crossref","first-page":"e235","DOI":"10.1097\/CCM.0000000000004784","article-title":"Efficacy of early prophylaxis against catheter-associated thrombosis in critically ill children: A Bayesian phase 2b randomized clinical trial.","volume":"49","author":"Faustino","year":"2021","journal-title":"Crit Care Med"},{"key":"R13-20250703","doi-asserted-by":"crossref","first-page":"e2022056726","DOI":"10.1542\/peds.2022-056726","article-title":"Enoxaparin thromboprophylaxis in children hospitalized for COVID-19: A phase 2 trial.","volume":"150","author":"Sochet","year":"2022","journal-title":"Pediatrics"},{"key":"R14-20250703","doi-asserted-by":"crossref","first-page":"10760296241271974","DOI":"10.1177\/10760296241271974","article-title":"Systematic review of randomized clinical trials on direct oral anticoagulants in pediatric heart diseases.","volume":"30","author":"Guan","year":"2024","journal-title":"Clin Appl Thromb Hemost"},{"key":"R15-20250703","doi-asserted-by":"crossref","first-page":"756","DOI":"10.3324\/haematol.2018.194175","article-title":"THROMBOTECT\u2014A randomized study comparing low molecular weight heparin, antithrombin and unfractionated heparin for thromboprophylaxis during induction therapy of acute lymphoblastic leukemia in children and adolescents.","volume":"104","author":"Greiner","year":"2019","journal-title":"Haematologica"},{"key":"R16-20250703","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.1016\/S2352-3026(23)00314-9","article-title":"Apixaban versus no anticoagulation for the prevention of venous thromboembolism in children with newly diagnosed acute lymphoblastic leukaemia or lymphoma (PREVAPIX-ALL): A phase 3, open-label, randomised, controlled trial.","volume":"11","author":"O\u2019Brien","year":"2024","journal-title":"Lancet Haematol"},{"key":"R17-20250703","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jpeds.2017.01.026","article-title":"Epidemiology of bleeding in critically ill children.","volume":"184","author":"White","year":"2017","journal-title":"J Pediatr"},{"key":"R18-20250703","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jcrc.2020.09.028","article-title":"Bayesian analysis of the epidemiology of bleeding in critically ill children.","volume":"63","author":"Greenway","year":"2021","journal-title":"J Crit Care"},{"key":"R19-20250703","doi-asserted-by":"crossref","first-page":"418","DOI":"10.3109\/08880018.2011.558568","article-title":"Diabetic ketoacidosis is associated with prothrombotic tendency in children.","volume":"28","author":"Bilici","year":"2011","journal-title":"Pediatr Hematol Oncol"},{"key":"R20-20250703","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1081\/ERC-120018678","article-title":"Diabetic ketoacidosis promotes a prothrombotic state.","volume":"29","author":"Carl","year":"2003","journal-title":"Endocr Res"},{"key":"R21-20250703","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3233\/CH-200957","article-title":"The effect of diabetic ketoacidosis (DKA) and its treatment on clot microstructure: Are they thrombogenic?","volume":"77","author":"Pillai","year":"2021","journal-title":"Clin Hemorheol Microcirc"},{"key":"R22-20250703","doi-asserted-by":"crossref","first-page":"102581","DOI":"10.1016\/j.rpth.2024.102581","article-title":"Hospital acquired venous thromboembolism (HA-VTE) among critically ill children with diabetic ketoacidosis: A multicenter, retrospective cohort study.","volume":"8","author":"DeMayo","year":"2024","journal-title":"Res Pract Thromb Haemost"},{"key":"R23-20250703","doi-asserted-by":"crossref","first-page":"198","DOI":"10.3389\/fped.2017.00198","article-title":"Pediatric hospital acquired venous thromboembolism.","volume":"5","author":"Witmer","year":"2017","journal-title":"Front Pediatr"},{"key":"R24-20250703","doi-asserted-by":"crossref","first-page":"e82","DOI":"10.1097\/PCC.0000000000003383","article-title":"Hospital-acquired venous thromboembolism and invasive mechanical ventilation: A report from the children\u2019s hospital acquired thrombosis consortium.","volume":"25","author":"Sochet","year":"2024","journal-title":"Pediatr Crit Care Med"},{"key":"R25-20250703","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1097\/PCC.0000000000003601","article-title":"Mechanical thromboprophylaxis and hospital-acquired venous thromboembolism among critically ill adolescents: A U.S. Pediatric Health Information Systems Registry study, 2016\u20132023.","volume":"26","author":"Betensky","year":"2024","journal-title":"Pediatr Crit Care Med"},{"key":"R26-20250703","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.4187\/respcare.11698","article-title":"Invasive mechanical ventilation and risk of hospital-acquired venous thromboembolism.","volume":"69","author":"Havlicek","year":"2024","journal-title":"Respir Care"},{"key":"R27-20250703","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1111\/j.1460-9592.2011.03595.x","article-title":"Are all ICUs the same?","volume":"21","author":"Wetzel","year":"2011","journal-title":"Paediatr Anaesth"},{"key":"R28-20250703","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.acap.2021.07.014","article-title":"Validation of neurologic impairment diagnosis codes as signifying documented functional impairment in hospitalized children.","volume":"22","author":"Nelson","year":"2022","journal-title":"Acad Pediatr"},{"key":"R29-20250703","first-page":"219706","article-title":"Diabetic ketoacidosis-associated stroke in children and youth.","volume":"2011","author":"Foster","year":"2011","journal-title":"Stroke Res Treat"},{"key":"R30-20250703","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.clim.2005.03.004","article-title":"Complement activation in diabetic ketoacidosis and its treatment.","volume":"116","author":"Jerath","year":"2005","journal-title":"Clin Immunol"},{"key":"R31-20250703","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.brainres.2010.10.085","article-title":"Oxidative damage is present in the fatal brain edema of diabetic ketoacidosis.","volume":"1369","author":"Hoffman","year":"2011","journal-title":"Brain Res"},{"key":"R32-20250703","doi-asserted-by":"crossref","first-page":"515","DOI":"10.4103\/0019-5049.144643","article-title":"Overview of the coagulation system.","volume":"58","author":"Palta","year":"2014","journal-title":"Indian J Anaesth"},{"key":"R33-20250703","first-page":"318","article-title":"Evaluation of the haemostatic system during ketoacidotic deterioration of diabetes mellitus.","volume":"29","author":"Ileri","year":"1999","journal-title":"Haemostasis"}],"container-title":["Pediatric Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/PCC.0000000000003769","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:56:31Z","timestamp":1786035391000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/PCC.0000000000003769"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,29]]},"references-count":33,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/pcc.0000000000003769","relation":{},"ISSN":["1529-7535","1947-3893"],"issn-type":[{"value":"1529-7535","type":"print"},{"value":"1947-3893","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,29]]}}}